Clinical Chemistry · 2006 · 133 citations · 13 references
PharmacyPharmaceutical AnalysisToxicologyAnalytical ChemistryAnalytical ToxicologyForensic ToxicologyAnalytical ChromatographyChromatographyGas ChromatographyInstrumental AnalysisMass SpectrometryToxicological Drug ScreeningGas Chromatography-mass SpectrometryLiquid Chromatography-mass SpectrometryLiquid Chromatography-mass Spectrometry AnalysisLiquid Chromatography-mass Spectrometry Method DevelopmentMass Spectrometric DetectionMass Spectrometric Drug AnalysisMass Spectrometry-based ScreeningReversed-phase Liquid Chromatography
BACKGROUND: In clinical and forensic toxicology, general unknown screening is used to detect and identify exogenous compounds. In this study, we aimed to develop a comprehensive general unknown screening method based on liquid chromatography coupled with a hybrid triple-quadrupole linear ion trap mass spectrometer. METHODS: After solid-phase extraction, separation was performed using gradient reversed-phase chromatography. The mass spectrometer was operated in the information-dependent acquisition mode, switching between a survey scan acquired in the Enhanced Mass Spectrometry mode with dynamic subtraction of background noise and a dependent scan obtained in the enhanced product ion scan mode. The complete cycle time was 1.36 s. A library of 1000 enhanced product ion-tandem mass spectrometry spectra in positive mode and 250 in negative mode, generated using 3 alternated collision tensions during each scan, was created by injecting pure solutions of drugs and toxic compounds. RESULTS: Comparison with HPLC-diode array detection and gas chromatography-mass spectrometry for the analysis of 36 clinical samples showed that linear ion trap tandem mass spectrometry could identify most of the compounds (94% of the total). Some compounds were detected only by 1 of the other 2 techniques. Specific clinical cases highlighted the advantages and limitations of the method. CONCLUSION: A unique combination of new operating modes provided by hybrid triple-quadrupole linear ion trap mass spectrometers and new software features allowed development of a comprehensive and efficient method for the general unknown screening of drugs and toxic compounds in blood or urine.
13
Christoph Mueller, Wolfgang Weinmann, Sebastian Dresen et al. · Rapid Communications in Mass Spectrometry · 2005 · 239 citations
How to improve estimates of imprecision.
Jan S. Krouwer, Ron Rabinowitz · Clinical Chemistry · 1984 · 160 citations
François‐Ludovic Sauvage, Jean‐Michel Gaulier, Gérard Lachâtre et al. · Therapeutic Drug Monitoring · 2006 · 97 citations
Pierre Marquet, Franck Saint‐Marcoux, T. Gamble et al. · Journal of Chromatography B · 2003 · 88 citations
Pharmacy, Chemistry, Toxicology +17